Merck & (MRK) Revenue — Quarter Ended Mar 31, 2023
Revenue for the quarter increased compared to the immediately preceding quarter. However, revenue declined relative to the same quarter one year earlier.
Key takeaway
Quarter ended Mar 31, 2023 · FY2023 Q1
Revenue for the quarter increased compared to the immediately preceding quarter. However, revenue declined relative to the same quarter one year earlier.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$14.5B
Revenue reported for this quarter.
Quarter-over-quarter
+4.8%
Change from the immediately preceding quarter.
Year-over-year
-8.9%
Change from the comparable year-ago quarter.
Trailing four quarters
$57.9B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Jun 30, 2022 | $14.6B | +28.0% |
| Sep 30, 2022 | $15B | +13.7% |
| Dec 31, 2022 | $13.8B | +2.3% |
| Mar 31, 2023 | $14.5B | -8.9% |
Revenue performance
The reported revenue direction is upward from the prior quarter. The sequential improvement follows a decline in the previous quarter.
Quarterly comparison
Compared to the immediately preceding quarter, revenue rose. Compared to the same quarter one year earlier, revenue fell.
What to watch
The filing context notes that cash provided by operating activities decreased significantly, partly due to lower sales of a specific product.